Workflow
GOLDSTONE ASIA PHARM.(300434)
icon
Search documents
金石亚药(300434.SZ):目前公司真空镀膜设备暂未涉及太空光伏设备制造领域
Ge Long Hui· 2026-01-27 08:16
格隆汇1月27日丨金石亚药(300434.SZ)在投资者互动平台表示,目前,公司真空镀膜设备暂未涉及太空 光伏设备制造领域;未来,公司将持续深入拓展真空镀膜技术在其他领域的研发、合作可能性。 ...
金石亚药(300434.SZ):目前,公司未开展涉及可控核聚变方面的业务
Ge Long Hui· 2026-01-19 15:35
格隆汇1月19日丨金石亚药(300434.SZ)在投资者互动平台表示,目前,公司未开展涉及可控核聚变方面 的业务。 ...
金石亚药(300434.SZ):全资子公司取得高新技术企业证书和专精特新中小企业证书
Ge Long Hui A P P· 2026-01-15 12:37
格隆汇1月15日丨金石亚药(300434.SZ)公布,公司之全资二级子公司浙江迪耳药业有限公司(简称"迪 耳药业")被认定为高新技术企业和专精特新中小企业。近日,迪耳药业分别收到了国家税务总局浙江 省税务局、浙江省财政厅、浙江省经济和信息化厅联合下发的《高新技术企业证书》(证书编号: GR202533006871,发证时间:2025年12月19日,有效期:三年)和浙江省经济和信息化厅下发的《浙 江省专精特新中小企业荣誉证书》(有效期:2025年12月至2028年12月)。 ...
金石亚药:全资子公司取得高新技术企业证书和专精特新中小企业证书
Ge Long Hui· 2026-01-15 12:17
格隆汇1月15日丨金石亚药(300434.SZ)公布,公司之全资二级子公司浙江迪耳药业有限公司(简称"迪 耳药业")被认定为高新技术企业和专精特新中小企业。近日,迪耳药业分别收到了国家税务总局浙江 省税务局、浙江省财政厅、浙江省经济和信息化厅联合下发的《高新技术企业证书》(证书编号: GR202533006871,发证时间:2025年12月19日,有效期:三年)和浙江省经济和信息化厅下发的《浙 江省专精特新中小企业荣誉证书》(有效期:2025年12月至2028年12月)。 ...
金石亚药:迪耳药业被认定为高新技术企业和专精特新中小企业
Mei Ri Jing Ji Xin Wen· 2026-01-15 11:43
每经头条(nbdtoutiao)——不到20万元,就能买特斯拉了?"廉价版"Model 3或进入中国市场,续航里 程480公里!关于自动驾驶,美国市场也有大调整 (记者 曾健辉) 每经AI快讯,金石亚药1月15日晚间发布公告称,四川金石亚洲医药股份有限公司之全资二级子公司浙 江迪耳药业有限公司被认定为高新技术企业和专精特新中小企业。 ...
金石亚药:子公司获高新技术企业证书
Xin Lang Cai Jing· 2026-01-15 11:34
金石亚药公告,全资子公司近日取得高新技术企业证书和专精特新中小企业证书。这标志着子公司在技 术创新和专业化发展方面得到认可,有助于提升公司的市场竞争力和品牌影响力。 ...
金石亚药(300434) - 关于全资子公司取得高新技术企业证书和专精特新中小企业证书的公告
2026-01-15 11:26
四川金石亚洲医药股份有限公司 关于全资子公司取得高新技术企业证书和 证券代码:300434 证券简称:金石亚药 公告编号:2026-001 根据《中华人民共和国企业所得税法》《中华人民共和国企业所得税法实施 条例》的有关规定,通过高新技术企业认定后,迪耳药业自获得高新技术企业认 定后的连续三年内,将享受国家关于高新技术企业的相关优惠政策,即按 15%的 税率计缴企业所得税。 上述两项证书的取得不会对公司当期经营业绩产生重大影响,敬请广大投资 者理性投资,注意防范投资风险。 特此公告。 四川金石亚洲医药股份有限公司 董 事 会 二〇二六年一月十五日 专精特新中小企业证书的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚 假记载、误导性陈述或重大遗漏。 四川金石亚洲医药股份有限公司(以下简称"公司")之全资二级子公司浙 江迪耳药业有限公司(以下简称"迪耳药业")被认定为高新技术企业和专精特 新中小企业。 近日,迪耳药业分别收到了国家税务总局浙江省税务局、浙江省财政厅、浙 江省经济和信息化厅联合下发的《高新技术企业证书》(证书编号: GR202533006871,发证时间:2025 年 12 ...
金石亚药:公司重点推广的石油、天然气工业用带式增强柔性复合管成套设备,国内外销售订单稳步上升
Mei Ri Jing Ji Xin Wen· 2025-12-29 01:13
金石亚药(300434.SZ)12月29日在投资者互动平台表示,公司自成立以来一直致力于增强塑料复合管 道全套生产工艺、技术解决方案及成套生产设备的研发、制造,为客户提供整厂方案规划、优质的设备 和服务,推动细分行业有序、健康、高质量发展。公司复合管道可应用于市政给排水、工业压力输送管 道、矿用耐磨管道、石油天然气集输管线等多种民用工业领域。近年来,公司重点推广的石油、天然气 工业用带式增强柔性复合管成套设备,以先进稳定的制造工艺和设备铆定国际市场并带动国内的应用试 点。2025年,该品类产品国内外的销售订单稳步上升,市场预期持续向好。 每经AI快讯,有投资者在投资者互动平台提问:公司的复合管道应用哪些领域?有没有量产? (文章来源:每日经济新闻) ...
金石亚药:复合管道应用于市政给排水、工业压力输送等多领域,2025年销售订单稳步上升
Sou Hu Cai Jing· 2025-12-29 01:05
Core Viewpoint - The company is focused on enhancing the production processes and technological solutions for composite pipes, aiming to provide comprehensive solutions for various industrial applications, particularly in the oil and gas sector [1]. Group 1: Company Focus and Applications - The company has been dedicated to the research and manufacturing of complete production processes and equipment for plastic composite pipes since its establishment [1]. - Composite pipes can be applied in various fields including municipal water supply and drainage, industrial pressure transmission, mining wear-resistant pipes, and oil and gas gathering pipelines [1]. - The company is particularly promoting its belt-reinforced flexible composite pipe equipment for the oil and gas industry, which is expected to gain traction in both domestic and international markets [1]. Group 2: Market Outlook - Sales orders for the company's products in the oil and gas sector are anticipated to steadily increase by 2025, with positive market expectations continuing [1].
2025年中国即食人参行业发展历程、市场政策、产业链图谱、市场规模、竞争格局及发展趋势分析:市场格局较为分散[图]
Chan Ye Xin Xi Wang· 2025-12-21 01:18
Core Insights - The core viewpoint of the article highlights the growing market for ready-to-eat ginseng products in China, driven by increasing health awareness among consumers, including not only the elderly but also young professionals and health-conscious individuals [1][10]. Industry Overview - Ready-to-eat ginseng is produced from ginseng through processes such as washing, steaming, slicing, drying, and flavoring, making it convenient for direct consumption while retaining essential nutrients [2]. - The market for ready-to-eat ginseng is projected to reach 28 billion yuan in 2024, with a year-on-year growth of 14.3% [1][10]. Development History - Historically, ginseng was consumed in its whole form, requiring complex preparation methods. The demand for convenient health supplements has led to the industrial development of ready-to-eat ginseng since 2011, driven by technological innovations and consumer upgrades [2][10]. - New technologies such as freeze-drying and bio-fermentation have been widely adopted, enhancing product quality and extending shelf life [2]. Regulatory Environment - Recent policies emphasize food safety and quality control across all stages of production, processing, and distribution of ready-to-eat ginseng, promoting a shift towards standardized and high-quality industry practices [4][5]. Industry Chain - The upstream of the ready-to-eat ginseng industry includes suppliers of raw materials like ginseng, honey, and packaging materials, while the midstream involves research, production, and processing [6]. - The downstream consists of various sales channels, including pharmacies, health product stores, and e-commerce platforms [6]. Market Competition - The ready-to-eat ginseng market is characterized by a fragmented competitive landscape, with the top five companies holding less than 40% market share in 2024 [12]. - Key players include Tongrentang, China Resources Sanjiu, and Yisheng Pharmaceutical, among others, each with distinct product offerings and market strategies [12][13]. Future Trends - The future of the ready-to-eat ginseng market will focus on standardized cultivation and innovative product forms to cater to diverse consumer needs, including portable packaging for convenience [16]. - There will be an increase in customized products targeting specific demographics, such as beauty products for women and fatigue-relief options for young professionals [16].